 Blog For Free!
Archives
Home
2005 October
2005 July
2004 November
2003 November
2003 October
My Links
my best journal
my other blog
my live journal
cryptome (the real thing)
THE RESPONSIBLE PARENT'S GUIDE
covalentbard
tBlog
My Profile
Send tMail
My tFriends
My Images
Sponsored
Blog
|
| 2001 Borna Virus looks more suspicious ! |
| 07.15.05 (7:36 am) [edit] |
[ my mood: fuck me ] |
|
|
This is the stuff that makes you wonder. First the virus can replicate in most warm-blooded animals and second it can induce neurological changes without physical signs. So theoretically it would seem possible for it to be residing in humanity at some level causing some effects without detection.
Clinical Microbiology Reviews, July 2001, p. 513-527, Vol. 14, No. 3 0893-8512/01/$04.00+0 DOI: 10.1128/CMR.14.3.513-527.2001
Borna Disease Virus and Human Disease Kathryn M. Carbone* FDA/CBER, HFM 460, Bethesda, Maryland 20892
http://intl-cmr.asm.org/cgi/content/full/14/3 /513" title="http://intl-cmr.asm.org/cgi/content/full/14/3 /513" target="_blank"http://intl-cmr.asm.org/cgi/c...
"Indeed, by natural or experimental inoculation, the ability of BDV to replicate in the nervous system of virtually every warm-blooded animal strongly suggests that BDV-like viruses are very unlikely to spare the human host.
Over the years, information has also accumulated about unusual features of BDV-induced disease in experimental animals such as rats, mice, and tree shrews. In these animals, BDV can induce behavioral disease (e.g., anxiety, aggression, cognitive defects, and hyperactivity) without obvious physiological signs of viral encephalitis (e.g., fever, neurological signs, and decreased level of consciousness)"
|
|
|
|
| |
| The progress as of 2000 |
| 07.15.05 (6:06 am) [edit] |
|
In summary, a critical evaluation indicates that no laboratory has to date been able to present solid evidence that BDV is infecting humans. Contamination problems may have clouded reality far more seriously than previously acknowledged.
|
|
|
| |
| Is this weird or lab contamination |
| 07.15.05 (6:05 am) [edit] |
|
Since all three patients lived in the United States of America, it remains an unsolved puzzle why they were infected with virtually the same strain of BDV that killed a horse in Germany more than 20 years ago.
|
|
|
| |
| Bootstrap analysis |
| 07.15.05 (6:03 am) [edit] |
|
This i suppose Is what I am doing. I wonder how much sense I can end up making out of this borna virus. I have a degree in biochemistry but all this stuff is really new and I only got a B.S..
|
|
|
| |
| Possibly a different Virus. Not Borna? |
| 07.15.05 (6:02 am) [edit] |
This whole thing is beginning to look like a shaky propasition. Like the search for the cause of Chronic Fatigue Syndrome which i still don't know if I believ in.
http://jgv.sgmjournals.org/cgi/content/full/81/9 /2123" title="http://jgv.sgmjournals.org/cgi/content/full/81/9 /2123" target="_blank"http://jgv.sgmjournals.org/cg...
"The alternative possibility remains that these antibodies were induced by infection with an antigenically related microorganism of unknown identity or exposure to some other related immunogen. In fact, recent data from our laboratory indicate that reactive human sera exhibit surprisingly low avidity for BDV antigens (Allmang et al., 2000 ), favouring the second possibility."
|
|
|
| |
| This Is where I propose a possible alien presence--Ha! Ha![ |
| 07.15.05 (5:28 am) [edit] |
|
|
A handful of strains. A handful of strain?
Intriguingly, nucleotide exchanges in the genome of classical European BDV strains are not distributed randomly. Rather, they cluster to well defined nucleotide positions in the p24 gene (Fig. 2) as well as other parts of the viral genome. Since these sites frequently map to third-codon (wobble) positions of the open reading frames, the exchanges do not usually affect the amino acid sequence of the viral proteins. It thus seems likely that some unrecognized functional constraints including secondary or tertiary RNA structures restrict sequence alterations to certain hot spots. Alternatively, the non-random distribution of base exchanges in the genomes of central European BDV strains might simply indicate that all known field isolates originate from just a handful of genetically stable progenitor strains. |
|
|
|
| |
| Why is Borna Virus so Provocative? |
| 07.15.05 (5:27 am) [edit] |
If Borna Virus turns out to be the cause of any percentage of mental illness then many people might come to accept mental illness as a real thing. If I discovered I had a virus that caused many of the problems in my life then I suppose I could feel better. No matter how much I believe I'm unhappy because of things I can't control I don't really believe it.
|
|
|
| |
| This articles Caveat About Borna Virus. |
| 07.15.05 (4:44 am) [edit] |
|
The previous article was written in 2000. It cautioned that some of the initial studies which caused so much excitement were not replicated. then An earlier post of mine i cite another study which answers those doubts with CIC's or circulating immune complexes. I wonder what they ARE?
|
|
|
| |
| Virus note #1 |
| 07.15.05 (4:42 am) [edit] |
From http://jgv.sgmjournals.org/cg... Epidemiology of Borna disease virus Peter Staeheli1, Christian Sauder1, Jürgen Hausmann1, Felix Ehrensperger2 and Martin Schwemmle1 'Numerous studies with experimentally infected rats and mice have conclusively demonstrated that BD is caused by immunopathological mechanisms in which the antiviral T cell response results in neurological disorder"
So the virus can cause a disease called borna disease.
The disease can remain clinically inapparent or it can cause severe neurological problems.
The natural hosts for the disease are farm animals.
Got to go
|
|
|
| |
| Psycho uptick #2 |
| 07.14.05 (2:17 am) [edit] |
|
|
|
Well I feel good now. I started two email conversations with girls at work. One was extremely upset. But unlike yesterday I didn't feel apart of it. It will work out ok i wrote it always does i wrote and it made sense to me at the time but she "no it doesn't" and i wrote you got your body and your mind. but that didn't work so then I........ |
|
|
|
| |
| Psycho uptick #1 |
| 07.14.05 (2:16 am) [edit] |
the car then computers and another wellbutrin. the doctor hadn't heard of abilify. the doctor thought I should tsper off the wellbutrin. the doctor went me more meds more lexapro more seroquel more strattera and a few small wellbutrin to taper with. the doctor came back with two months of lexapro and strattera and suprisingly seven bottles of wellbutrin. does the doctor know what she is doing? late sixties german accent free clinic walks like her entire back is fused together. I don't know? Hadn't heard of borna virus but then she hadn't heard of abilify and it's been out for 2 or three years. But then she was a hero she got me two months of seroquel but at twice my dose. oh well it helps me sleep. After the appointment I chewed 150mg welbutrin xr then a half a seroquel. continued.
|
|
|
| |
| It's another morning of psychopoetry |
| 07.14.05 (2:14 am) [edit] |
|
|
This morning started with a nice dig at my chin.
Then a no-doze and a wellbutrin
I found some temporary peace
What to do what to do.
I think I can't deal with sex.
I don't think I'm comfortable with any of it.
Why do I feel like i'm missing the point.
I wish there was a point to miss.
I read so many things once.
So much fluffy ethereal nonsense.
I want the earth and I want it now |
|
|
|
| |
| Well I'm actually going to see the doctor at the free clinic tomorrow |
| 07.14.05 (2:13 am) [edit] |
I have the full time job you're supposed to have. I have the spiritual program you're supposed to have. I'm doing the things I'm Supposed to to.
Is that a bunch of bullshit? it's hard to tell.
where to begin and where to end
|
|
|
| |
| Treatment resistant depression - |
| 07.14.05 (2:11 am) [edit] |
|
Aripiprazole
A third generation Antipsychotic, an atypical atypical neuroleptic. Zyprexa worked well for me once but I couldn't stand the weight gain or the stupidity. The side affect profile of this is much nicer however and the "doctors" give them out like candy. It Makes Ya Act Right!
Aripiprazole augmentation in treatment-resistant depression.
Barbee JG, Conrad EJ, Jamhour NJ.
Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. jbarbe@lsuhsc.edu
BACKGROUND: Evidence is accumulating to support the use of atypical neuroleptics as adjunctive treatment for refractory mood disorders, although there are currently no published data on the efficacy of an atypical neuroleptic in treatment-resistant depression when a previous trial of drug from the same class has failed. The authors hypothesized that aripiprazole would be efficacious in augmenting antidepressant treatment in resistant patients with non-psychotic unipolar depression who had previously failed a trial of another atypical neuroleptic. METHODS: This study was a retrospective chart review of the efficacy of aripiprazole augmentation in 30 treatment-resistant unipolar depression patients who had failed multiple previous antidepressant trials and had also failed augmentation with at least one other atypical neuroleptic. Prospective Global Assessment of Functioning and Clinical Global Impressions-Improvement scores were completed on each patient throughout treatment. RESULTS: Utilizing an intent-to-treat analysis (including 9 patients who dropped out prior to completion of 6 weeks), 46.7% (14/30) patients were rated much improved or very much improved with treatment. This improvement negatively correlated with Thase-Rush staging of treatment resistance. GAF scores also showed a significant improvement. Six of the 14 patients who initially improved subsequently relapsed (yielding a long-term net response rate of 26.7%). CONCLUSION: Aripiprazole may be effective as an antidepressant augmentation agent in highly treatment resistant patients who had failed a prior trial of another atypical neuroleptic.
|
|
|
| |
| Borna virus and Affective Disorders |
| 07.12.05 (11:17 am) [edit] |
|
This a is new and interesting article that explains, among other things, that the detection of CIC's puts the earlier negative studies concerning human borna virus infection into doubt. Some excerpts are below and the free full text is available.
=http://cmr.asm.org/cgi/pmidlo...;pmid=12857781" Borna disease virus infection, a human mental-health risk.
Bode L, Ludwig H.
Project Bornavirus Infections, Robert Koch Institute, 13353 Berlin, Germany.
As detailed elsewhere (8), CICs(antibody-bound circulating immune complexes (CICs)) represent the prevailing infection marker and are found in more than 90% of patients with a major depressive disorder or bipolar disorder during acute depression.
Long-term follow-up studies of patients are particularly important in major affective disorders because the patients' condition alternates between disease and good health.
changes in the relative amounts of CIC and plasma antigen over time can be monitored precisely and even allow a prognostic estimate, e.g., large plasma antigen amounts correlated significantly with the severity of depression in major depressive disorder and bipolar disorder patients (8), whereas decline of these markers coincided with clinical improvement
The discovery of CICs after years of controversy due to low antibody titers or “disappearing” antibodies explains many previous discrepancies (1, 2, 12, 21, 24, 32, 38, 46, 58). Moreover, the existence of BDV CICs and antigenemia has provided insight into the dynamics of a poorly understood equilibrium of plasma antigen, antibodies, and CICs during persistent BDV infection and its impact on clinical features (9).
Among patients in the acute stage, 40 to 50% had BDV antigen-positive PBMCs in the group of severe cases (4, 8, 9, 22a), and the probability of isolating virus increased considerably with increased disease severity (6). Most of the acutely depressed major depressive disorder and bipolar disorder patients were CIC positive (>90%), and the severity of symptoms correlated with high plasma levels of CIC and antigen (Fig. 1). Among patients of all clinical categories of depression in the study, about 50% were CIC positive (8).
Unlike schizophrenia, major affective disorders (major depressive disorder and bipolar disorder) have become increasingly linked with activated BDV infection.
|
|
|
| |
| Fuck this |
| 07.12.05 (7:33 am) [edit] |
|
Personally I believe I have treatment resistant depression but then maybe it's Borderline personality Disorder or perhaps a combination of things. Whatever the diagnosis I want to attach to it, it seriously blows. In fact my entire life history pretty much sucks. Well it is time to get proactive and fix this deal.
|
|
|
| |
| Neonatal rats effected by Borna Virus- Early brain injury model |
| 07.12.05 (5:25 am) [edit] |
|
This abstract proposes that the borna virus effects the 5ht brain system.
Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: a multidisciplinary analysis.
Dietz D, Vogel M, Rubin S, Moran T, Carbone K, Pletnikov M.
Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21205, USA.
Neonatal Borna disease virus (BDV) infection of the rat brain serves as a valuable model for studying the pathogenesis of neurodevelopmental abnormalities following early brain injury. Previous experiments have demonstrated significant alterations in regional tissue content of serotonin (5-HT) in neonatally BDV-infected Lewis rats. The present study sought to provide more insights into postnatal virus-associated alterations in 5-HT neurotransmission by evaluating the density of 5-HT1a receptors in the hippocampus and 5-HT2a receptors in the cortex, regional 5-HT tissue concentrations, behavioral responses to a 5-HT agonist, quipazine, and numbers of neurons in specific subfields of the hippocampus on days 7, 14, and 30 after neonatal BDV infection in Lewis rats. Neonatal BDV infection was found to be associated with a gradual increase in the density of 5-HT2a and 5-HT1a postsynaptic receptors followed by an elevation of 5-HT contents at both the levels of synaptic terminals (i.e., cortex and hippocampus) and cell bodies (i.e., raphe nuclei). In addition, there was an enhanced behavioral response to quipazine. Virus-associated neurochemical and behavioral changes were accompanied by a decline in the number of neurons in the dentate gyrus and in the CA1 field of the hippocampus. No change in the number of neurons in the CA3/2 field of the hippocampus was observed. The present pattern of BDV-associated alterations in 5-HT brain system along with available data from other laboratories suggest that BDV might compromise axonal transport and/or release of 5-HT, resulting in decreased 5-HT neurotransmission.
PMID: 15385249 [PubMed - indexed for MEDLINE]
|
|
|
| |
| Borna Virus Human exposure meta-Analysis |
| 07.12.05 (4:53 am) [edit] |
|
Here is a meta-analysis that supports the human exposure to Borna Virus
The studies referenced are all dated prior to january 2000.
Borna disease virus and the evidence for human pathogenicity: a systematic review.
Chalmers RM, Thomas DR, Salmon RL.
NPHS Communicable Disease Surveillance Centre, Abton House, Wedal Road, Cardiff CF14 3QX, UK.
BACKGROUND: Borna disease is a neurological viral disease of veterinary importance in central Europe, although Borna Disease virus (BDV) has been reported to be present in animals in most continents. The hypothesis that BDV is associated with human illness is controversial. However, should even a small fraction of mental illness be attributable to infection with BDV, this would be an important finding, not least because illness in that sub-population would, theoretically, be preventable. METHODS: We systematically reviewed the evidence: that BDV infects humans; for the role of BDV in human neuropsychiatric illness; to assess the suitability of currently available laboratory methods for human epidemiological studies. RESULTS: We identified 75 documents published before the end of January 2000, describing 50 human studies for BDV. There were five case studies and 44 (sero)prevalence studies, in a variety of patient groups. Nineteen prevalence studies (43%) investigated seroprevalence, 11 (25%) investigated viral prevalence and 14 (32%) investigated both. Seroprevalence ranged from 0% to 48%, and prevalence of virus or viral footprints from 0% to 82%. DISCUSSION: Although agreed gold standard tests and evidence for test specificity are lacking, there is evidence that humans are exposed to the virus. Further epidemiological studies are required to establish whether there are associations with disease.
Publication Types:
PMID: 15760926 [PubMed - indexed for MEDLINE]
|
|
|
| |
| Borna Virus Mechanism in Psychiatric illness |
| 07.12.05 (4:45 am) [edit] |
This looks like a possible mechanism. Neuronal plasticity Neuronal plasticity is a phenomenon in which neurons react to changed conditions by making new connections or using existing connections in different ways. Borna disease virus interference with neuronal plasticity.
Gonzalez-Dunia D, Volmer R, Mayer D, Schwemmle M.
Avenir Group, Inserm U563, CPTP Bat B, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3, France.
Viruses able to infect the central nervous system (CNS) are increasingly being recognized as important factors that can cause mental diseases by interfering with neuronal plasticity. The mechanisms whereby such infections disturb brain functions are beginning to emerge. Borna disease virus (BDV), which causes a persistent infection of neurons without direct cytolysis in several mammalian hosts, has recently gained interest as a unique model to study the mechanisms of viral interference with neuronal plasticity. This review will summarize several hypotheses that have been put forward to explain possible levels of BDV interference with brain function.
PMID: 15885838 [PubMed - in process]
|
|
|
| |
| Borna virus Chronic Fatigue Syndrome |
| 07.12.05 (4:26 am) [edit] |
This study says that borna virus was found in 20 percent of these "chronic fatigue" sufferers but in only 6 percent of the control group!
Zhonghua Yi Xue Za Zhi. 2005 Mar 16;85(10):701-4. |
Related Articles,
Links |
[Clinical characteristics of patients with chronic fatigue syndrome: analysis of 82 cases]
[Article in Chinese]
Li YJ, Wang DX, Bai XL, Chen J, Liu ZD, Feng ZJ, Zhao YM.
Department of Neurology, People's Hospital, Beijing University, Beijing 100044, China.
OBJECTIVE: To analyze the clinical characteristics of Chinese patients suffering from chronic fatigue syndrome (CFS) and provide clinical and laboratory evidence for the study of its etiology and treatment. METHODS: 82 patients with CFS diagnosed based on the CDC criteria 1994 were recruited. History was collected, and physical examination was made. SCL-90 and memory test were used, and Hamilton Anxiety Rating Scale was used to those showing depression and/or anxiety. Laboratory examination, including examination of electrolytes, blood sugar, creatinine, bilirubin, alkaline phosphatase, alanine trasaminase, etc, was conducted. Western blotting was used to detect the protein-24 of Borna disease virus (BDV) in the plasma of 61 patients and 73 healthy controls. High-pressure chromatography was conducted to detect n-6 fatty acids on the membrane of erythrocytes of 42 patients and 37 healthy controls. Plasma L-carnitine in 61 patients and 73 healthy controls was detected by zymological analysis. In different examinations sex and age-matched controls were used. RESULTS: Most of the patients were 21 approximately 50 years old (74/82, 90.24%). No gender difference was found. The patients usually had 4 approximately 6 symptoms besides distinctive fatigue. Descent of remembrance and/or attention was the most conspicuous accompanying symptoms (69/82, 84.15%). Abnormalities in SCL-90 scores were present in 57 patients (69.51%), e.g, somatization existed most commonly (32/82, 39.02%), and anxiety and depression were 20.73% (17/82) and 18.29% (15/82) respectively. The prevalence of anti-BDV-p24 antibody was 20.73% (17/82), significantly higher than that of the controls (0%, chi(2) = 6.673, P = 0.010). The arachidonic acid level was significantly lower in the CFS group than in the controls (P > 0.05) and there were no differences in linoleic acid and ETA (both P > 0.05). The level of L-carnitine was 6.4336 +/- 3.4225, significantly lower than that of the control group (7.6666 +/- 3.5819, t = 2.025, P = 0.045) and the L-carnitine level was increased 2 weeks after supplementary treatment, together with improvement of symptoms. CONCLUSION: Most of the CFS patients are young and middle-aged. Descent of reorganization is common in these patients. Psychological abnormalities exist in most patients. Some patients are infected with BDV, some with deficiency of nutrition and/or abnormality of energy metabolism.
PMID: 15932738 [PubMed - in process]
|
|
|
| |
| New directions |
| 07.12.05 (3:54 am) [edit] |
|
I figure that I've always been totally fucked when it comes to just about everything. But I've been reading about some new reseach and I thought I'd just collect it here on this blog.
|
|
|
| |
|
|